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Abstract
Purpose of the review Non-invasiveness and instanta-
neous diagnostic capability are prominent features of the
use of echocardiography in critical care. Sepsis and septic
shock represent complex situations where early hemody-
namic assessment and support are among the keys to
therapeutic success. In this review, we discuss the range of
applications of echocardiography in the management of the
septic patient, and propose an echocardiography-based
goal-oriented hemodynamic approach to septic shock.
Recent findings Echocardiography can play a key role in
the critical septic patient management, by excluding car-
diac causes for sepsis, and mostly by guiding hemody-
namic management of those patients in whom sepsis
reaches such a severity to jeopardize cardiovascular func-
tion. In recent years, there have been both increasing evi-
dence and diffusion of the use of echocardiography as
monitoring tool in the patients with hemodynamic com-
promise. Also thanks to echocardiography, the features of
the well-known sepsis-related myocardial dysfunction have
been better characterized. Furthermore, many of the recent
echocardiographic indices of volume responsiveness have
been validated in populations of septic shock patients.
Conclusion Although not proven yet in terms of patient
outcome, echocardiography can be regarded as an ideal
monitoring tool in the septic patient, as it allows (a) first
line differential diagnosis of shock and early recognition of
sepsis-related myocardial dysfunction; (b) detection of pre-
existing cardiac pathology, that yields precious information
in septic shock management; (c) comprehensive hemody-
namic monitoring through a systematic approach based on
repeated bedside assessment; (d) integration with other
monitoring devices; and (e) screening for cardiac source of
sepsis.
Keywords Sepsis  Septic shock  Echocardiography 
Hemodynamic monitoring  Endocarditis  Critical care
Rationale for the use of echocardiography in the septic
critical patient
Sepsis and septic shock (SS) are common causes of car-
diovascular failure in critical care and are the most frequent
causes of mortality in intensive care units [1, 2]. SS is one
of the most complex hemodynamic failure syndromes, as it
may imply derangement of all the three mainstays of car-
diovascular homeostasis, each one to a variable degree:
absolute or relative reduction in central blood volume,
peripheral vasodilatation and myocardial failure may
coexist and variably overlap in different phases of septic
shock’s course [3, 4]. Echocardiography (ECHO) has
nowadays acknowledged clear indications in hemodynamic
instability [5], is increasingly used by intensive and critical
care physicians, and is advocated by many as an
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irreplaceable tool in the approach to and management of
the critical patient [6–8]. Many are the reasons that make
ECHO suitable for guiding hemodynamic management of
septic critical patients at different stages of their critical
illness: (1) non-invasiveness, rapidity—in adequately
trained hands ECHO has the potential to non-invasively
provide at the bedside instantaneous relevant diagnostic
information on patients’ cardiovascular status [9, 10]. Even
though a comprehensive ECHO examination may be time
consuming, time required for a focused, limited ECHO
examination ranges from seconds to a dozen of minutes
[11, 12]; (2) diagnostic yield, monitoring capabilities—
ECHO offers the matchless advantage to perform both
detailed functional and morphological assessment of the
heart; pathological changes in venous return and vascular
tone can then be assessed with dynamic investigation of
their consequences on the heart and the great vessels [13–
15]; (3) impact on patient management—even in patients
already monitored invasively, both transthoracic ECHO
(TTE) and transesophageal ECHO (TEE) add new relevant
information that leads to changes in therapy in more than
50% of cases [12, 16, 17], the majority of which concern
volume status and inotropy [17]; (4) flexibility—its use is
scalable from a limited/focused to a comprehensive
examination, according to time available and complexity of
clinical queries. Either TTE or TEE can alternatively be
used, according to availability and to the specific infor-
mation needed; (5) accuracy—the use of ECHO as hemo-
dynamic monitoring tool has already been validated in
populations of septic shock patients [14], so as have been
many of the most recent ECHO indices of volume
responsiveness [18]. ECHO seems to be more accurate than
the standardized strategy proposed by the Surviving Sepsis
Campaign guidelines in the detection of the dominant
features of the failing circulation [19]. Indeed, a simplified
qualitative approach has demonstrated to be accurate
enough [20]; (6) specific cardiac issues related to sepsis—
the heart, main target of the ECHO examination, frequently
represents itself the core of the septic process, being either
‘‘a victim’’ (when sepsis-related myocardial dysfunction
develops) or its source (in the context of endocarditis).
The purpose of this review was to describe ECHO
applications and potential findings in the critical septic
patient, and provide a framework for the practical approach
with Echo to SS management, both at onset and in the
subsequent course of the disease.
Early management of the septic shock patient: focused
echocardiography
Sepsis mortality is directly linked to hemodynamic instability
resulting in tissue hypoxia, and prompt support aimed at
specific hemodynamic targets has been demonstrated to
reduce it significantly [21], up to saving the lives of one in six
sepsis patient [22]. One key component of early goal-directed
therapy strategies in SS is the accurate hemodynamic
assessment and recognition of the dominant feature of the
failing cardiovascular system (defective volume or vascular
tone, failing heart pump) with subsequent appropriate man-
agement [23, 24]. Consistently with this need to accelerate the
correct treatment, bedside TTE in the early phase of undif-
ferentiated shock sharply reduces the number of viable
diagnosis [25]. Focused ECHO findings typical of early SS
(Table 1) are represented by signs of profound hypovolemia:
ventricular hyperkinesia [small hypercontractile left
ventricle, LV, with end-systolic obliteration of cavity [26]
(Fig. 1a–c, Video 1A, B ESM), small hypercontractile right
ventricle, RV] and small inferior vena cava with marked
respiratory variations [27, 28] (Figs. 1e, f, 2a). Once this
hemodynamic pattern has been detected, matched with clin-
ical findings to make a presumptive diagnosis, and hemody-
namic support started, an increase in inferior vena cava size
[27] and in right and left ventricular end-diastolic dimensions
[29] is expected with progression of volume resuscitation
(Fig. 2b, c, Video 1 ESM). Persistent small end-systolic
dimensions suggest then vasodilatation and need for vaso-
constrictors upward titration. Furthermore, early perfor-
mance of focused echo allows for timely screening of sepsis-
related myocardial dysfunction and hence more careful fluid
administration and early inotropic support (vide infra).
SS superimposing on pre-existing cardiac dysfunction,
or sepsis-triggered cardiac derangements (myocardial
ischemia), or aggressive mechanical ventilation (hindering
RV function in the context of ARDS, pneumonia) may
determine from the beginning a different pattern, where
typical features are missing, and RV or LV dysfunction
appears as the main finding. Recognition of a relevant
Table 1 Echocardiographic findings at shock onset
Small LV
Small RV
LV and RV hyperkinesia
Small IVC
IVC respiratory collapse (spontaneous ventilation)
None of the above (but rather a variable degree of LV or RV
dysfunction) in the setting of relevant pre-existing cardiac disease
Typical echocardiographic findings at septic shock onset are repre-
sented by signs of severe hypovolemia and biventricular hyperkinesia
(effect of co-existing vasodilatation and hypovolemia). These findings
are easily recognizable with a TTE focused ECHO examination. Put
in the clinical context of a febrile patient with a known/suspected
septic focus, this pattern suggests diagnosis of septic shock. Recog-
nition of signs of pre-existing cardiac disease avoids misdiagnosis of
primary cardiogenic cause of shock in a chronic heart failure with
septic shock
LV left ventricle, RV right ventricle, IVC inferior vena cava
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dilatation of any cardiac chamber other than the RV (the
only chamber that can dilate acutely) or dilatation and
hypertrophy of the RV gives clues toward a subjacent
chronic dysfunction, avoids misdiagnosis of a primary
cardiogenic aetiology of shock [15], and bears prognostic
information linked to relevant co-morbidity. Severe LV
hypertrophy and/or LV diastolic dysfunction may represent
potential pitfalls on ventricular size-based volume status
assessment: in this case, persistent LV small dimension
does not equate to safe fluid infusion. Fluid administration
should altogether not be gauged on LV or RV dimensions
in the aforementioned settings of co-existing chronic heart
disease, but rather on inferior vena cava size, when small,
and on volume-responsiveness indices (vide infra).
Additional focused ultrasound investigations (lung,
abdominal, soft tissues, beyond the scope of this review)
in a multi-focused transversal approach [30, 31] should
help in confirming suspicion of a septic etiology of the
critical state and save time in early institution of empir-
ical antibiotic therapy, upon appropriate bacteriological
sampling.
Monitoring the patient with septic shock:
comprehensive echocardiography
While pattern recognition may suffice in the very early
approach to SS [32], with ongoing resuscitation or more
Fig. 1 Septic shock at its onset,
in hospital-acquired pneumonia,
3rd postoperative month of
double lung transplant. Patient
intubated and mechanically
ventilated. SAP 85/40 mmHg,
HR 160 bpm, with signs of
inadequate tissue perfusion.
TTE subcostal 4-chamber view
(upper panels, Video 1A ESM)
and parasternal short axis
midpapillary view (middle
panels, Video 1B ESM) show a
hyperkinetic pattern, with
marked reduction of LV and RV
size from end-diastole (a, c) to
end-systole (b, d). Inferior vena
cava (subcostal IVC view, lower
panels) is small (e) and shows
significant increase in size with
mechanical passive inspiration
(f). RA right atrium, RV right
ventricle, LA left atrium, LV left
ventricle, IVC inferior vena
cava
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complex situations (ex. co-existing disease), a systematic
step-by-step assessment is necessary to monitor hemody-
namics. Repeated bedside assessment at each hemody-
namic deterioration or significant therapeutic variation is
the key to the use of Echo in this hemodynamic fashion
[14] and allows for prompt recognition and correction of
the specific causes of cardiovascular instability, which is
mandatory in SS management [20, 24, 33]. ECHO findings
should be appropriately interpreted in the clinical context
and integrated with available data from other monitoring
tools (systemic arterial mean pressure, central venous
pressure and saturation, arterial blood lactates, urine out-
put), especially with the ones concerning the adequacy of
tissue perfusion, on which echocardiography is blind. TEE
always enables a complete assessment, inclusive of
detailed heart–lung interactions and fine volume respon-
siveness evaluation, cardiac output assessment, and left-
ventricular end-diastolic pressures estimation, when
required. When adequate views can be achieved, TTE
allows for even less invasive and thus more repeatable
assessment, especially once key hemodynamic features
have already been focused. ECHO reporting and storage of
images and video clips allow for accurate comparison of
findings obtained at different time spots and should thus be
mandatory.
ECHO assessment should systematically seek for the
following situations (Table 2), with the aim to guide fluid
therapy and inotropic/vasoconstrictor support institution
and titration:
Low output state
Stroke volume is calculated through Doppler sampling of
LV outflow tract (LVOT) flows (TTE 5 chamber view or
TEE deep TG/TG LAX view), and is feasible provided the
absence of aortic valve pathology [34]. Doppler sampling
provides the time–velocity integral of blood exiting the
LV; this integral (a distance) is then multiplied by the
calculated cross sectional area of the LVOT itself (TTE
parasternal LAX view/ME LAX view), yielding a volume,
the stroke volume and then turned into cardiac index
(Fig. 3a, b). This method actually provides an estimation of
cardiac index rather than a precise determination: most
validation studies using thermodilution as gold standard for





Very small IVC end-expiratory
diameter (a right side) and
marked inspiratory collapse
(a, M-mode scanning, left side)
are in favor of severe
hypovolemia. Subsequent
volume loading (colloids
1,000 ml, crystalloids 300 ml),
improves SAP. This is
paralleled by a progressive
increase in IVC end-expiratory
size (b, c, red double-headed
arrows). IVC inferior vena cava,
RA right atrium, INSP
inspiratory phase of respiratory
cycle, SAP systemic arterial
pressure, HR heart rate
Table 2 Targets of the echocardiographic hemodynamic assessment
Cardiac output
Volume status, volume responsiveness
LV systolic function
RV systolic function
Systemic arterial resistances (indirect, exclusion criteria)
LV filling pressures
To monitor the septic shock patient, major hemodynamic variables
are assessed non-invasively, mainly by semi-quantitation. Systemic
arterial resistances, together with indices of global perfusion, cannot
be measured with echocardiography, but vasodilatation can be diag-
nosed with exclusion criteria. See systematic approach in Fig. 8
LV left ventricle, RV right ventricle
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cardiac output measurement reported limits of agreement
with TEE reaching ± 1 L/min [35]. In practice, ECHO is
used to semi-quantify cardiac index (i.e. to allocate patients
into ranges of values: very low/low/normal/high), and most
usefully to evaluate variations following therapeutic
maneuvres (Fig. 3c). Relying upon the LVOT velocity–
time integral, rather than calculated stroke volume, elimi-
nates the major source of error (i.e. LVOT cross-sectional
area calculation). Furthermore, the issue of potential
inaccuracy of thermodilution should not be overlooked
[36]. Due to peripheral flow distributive derangements,
usual normal values of CI should not be considered nec-
essarily adequate in SS. Other ways to calculate the stroke
volume include the 2D-based modified Simpson’s rule and
the M-mode-based Teicholz method; even if easier in their
approach, they are not sufficiently accurate to be recom-
mended as routine practice.
Inadequate central blood volume
After the first phase of shock resuscitation, signs of severe
hypovolemia may still exist and be detected as a small LV
end-diastolic area (LVEDA, easily measured in a TTE
parasternal short axis or in a TEE transgastric midpapillary
view). But most frequently a volume-resuscitated shock
will need a volume responsiveness assessment in order to
unmask a persistent preload defect [37]. Volume respon-
siveness can be detected with various ECHO indices
(Table 3), but this assessment must be tailored to the
clinical setting. In fully passive mechanically ventilated
patients with sinus rhythm, indices derived from study of
heart–lung interactions are highly accurate: C12.5%
respiratory variation of LV ejection [38], C18% inferior
vena cava distensibility [39] (TTE subcostal view), or
C36% superior vena cava collapsibility [40] (TEE bicaval
view) are validated cutoffs, with sensitivities and speci-
ficities ranging from 90 to 100% (Fig. 4). Low tidal vol-
umes may yield false negatives [41], and severe RV
dysfunction, for LVOT flows-based indices, false positives
[42]. Spontaneous breathing and/or non-sinus rhythm
requires a passive leg-raising test: a C12.5% LVOT
velocity–time integral increase upon shift of patient posi-
tion from 45 trunk elevation to 45 leg raising is predic-
tive of SV increase with volume loading (Fig. 2 ESM) with
77% sensitivity and 100% specificity [43]. False nega-
tives to the test may occur, especially in the context
of abdominal hypertension for values of intrabdominal
pressure [16 mmHg [44]. When still in doubt, an Echo-
monitored fluid challenge (the search for C15% Echo-
measured stroke volume increase upon a limited fluid bolus
infusion) is indicated as last choice. Of note is that the
existence of volume responsiveness is better supported by a
bundle of ECHO findings rather than a single positive
Fig. 3 TEE Doppler assessment of cardiac output in a community-
acquired pneumonia patient with septic shock (same patient of Fig. 5).
Patient is hypotensive and badly perfused and 2D images show a pattern
of biventricular dysfunction. LVOT diameter is measured in a mid-
esophageal long axis view (a, red double-headed arrow) and LVOT
cross sectional area calculated (LVOT diameter = 2.23 cm; CSA =
1.115 cm 9 1.115 cm 9 3.14 = 3.90 cm2). Measured LVOT VTI
(panel 3B, TEE transgastric long axis view) is 8.7 cm, calculated
stroke volume is 34 ml (3.90 cm2 9 8.7 cm), and heart rate 104 bpm,
yielding a CO of 3.55 L/min. Epinephrine infusion [0.01 mcg/
(kg min)] restores adequate pressures and flows, increasing LVOT
VTI to 12.7 cm, SV to 49 ml (3.90 cm2 9 12.7 cm), heart rate to
120 bpm and CO to 5.83 L/min (c). LVOT left ventricular outflow tract,
VTI Doppler velocity–time integral, CO cardiac output
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index, and that it does not necessarily equate to the need for
fluid infusion (absolute hypovolemia correction); also
recruitment of unstressed volume from the venous reservoir
(relative hypovolemia correction) may increase cardiac
output [45, 46]: when an upward titration of vasocon-
strictors determines an increase in stroke volume, this may
Table 3 Echocardiographic indices of volume responsiveness
DVpeak 100 (Vpeakmax - Vpeakmin)/(Vpeakmax ? Vpeakmin)/2 [C12%] [36]
IVC distensibility index 100 (IVCend-insp - IVCend-exp)/IVCend-insp [C18%] [37]
SVC collapsibility index 100 [(SVCend-exp - SVCend-insp)/SVCend-exp] [C36%] [38]
Response to PLR test (SViPLR - SVibasal)/SVibasal [C12.5%] [38]
Volume responsiveness can be accurately detected in passive mechanically ventilated and sinus rhythm patients through assessment of IVC and
SVC diameter respiratory variations, and through LV ejection respiratory variations. In spontaneously breathing or mechanically ventilated but
actively breathing patients, and/or non-sinus rhythm patients, these indices are inaccurate, and a passive leg-raising test is required. Cutoff values
for volume responsiveness of each index are indicated in square brackets
Vpeak, peak velocity of transaortic flow; DVpeak, aortic flow respiratory variation index; Vpeakmax, maximum Vpeak velocity; Vpeakmin
minimum Vpeak velocity; IVC, inferior vena cava; IVCend-insp, IVC diameter at end inspiration; IVCend-exp, IVC diameter at end expiration;
SVC, superior vena cava; SVCend-exp, SVC diameter at end expiration; SVCend-insp, SVC diameter at end inspiration; PLR, passive leg raising;
SVibasal, stroke volume index at 45 trunk elevation; SViPLR, stroke volume index during PLR (45 leg raising)
Fig. 4 Volume responsiveness
assessment by means of heart–
lung interaction-derived indices,
in a mechanically ventilated
passive patient with septic
shock. Septic shock patient with
peritonitis caused by colonic
perforation. Left-sided panels
show a volume responsiveness
status, with marked respiratory
SVC collapsibility (56%; a,
TEE bicaval view, M-mode
scanning), IVC distensibility
(32%; c, TEE transgastric off-
axis view on the IVC, M-mode
scanning) and marked LV
ejection respiratory variations
(36%; e, TEE deep transgastric
view, Doppler sampling of
LVOT velocities). After
1,500 ml fluid infusion, these
respiratory variations are greatly
reduced and the various indices
show now absence of volume
responsiveness (right-sided
panels): SVC collapsibility 18%
(b), IVC distensibility 5% (d),
LV ejection respiratory
variations 10% (f). SVC superior
vena cava, IVC inferior vena
cava, SVCexp SVC diameter at
end-expiration, SVCinsp SVC
diameter at end-inspiration,
IVCinsp IVC diameter at end-
inspiration, IVCexp IVC
diameter at end-expiration,
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be the preferred choice toward limiting harmful positive
fluid balance [47].
LV systolic dysfunction
LV systolic function is assessed either visually (qualita-
tively), or by means of widely used 2D measurements
(quantitatively). These are based on the percentage varia-
tion of LV size from end-diastole to end-systole, either
referring to its diameter (FS, fractional shortening), its area
(FAC, fractional area change), or its volume (EF, ejection
fraction).
LV sepsis-related myocardial dysfunction is nowadays a
well-known entity [48], and both global and regional sys-
tolic wall motion abnormalities can be found [49, 50]. A
so-called hypodynamic pattern (low cardiac index associ-
ated with reduced ejection fraction, EF, below 40–45%) is
described in up to 60% of SS patients [14, 51]: its detection
should prompt inotropes administration, even if central
venous pressure values indicated by guidelines as target for
ceasing volume loading have not been reached yet (further
increase in preload on an acutely failing LV may not only
fail to increase oxygen delivery but may also cause harm).
Sequential determinations of EF, FAC and FS will allow
for appreciation of LV dysfunction’s complete recovery in
survivors (Fig. 5, Video 5A, C ESM) [52, 53]. Time pat-
tern of this phenomenon has been characterized: dysfunc-
tion appears usually on day 1 roughly in two-thirds of
affected patients, on day 2–3 in the other third, while
recovery takes 7–10 days. (Fig. 3 ESM) [51]. As sepsis-
related myocardial dysfunction can be masked by associ-
ated vasodilatation and preload inadequacy, LV systolic
function should always be re-assessed after preload and
afterload optimization (Fig. 6, Video 6A, B). Conversely to
what previously believed, there is no LV adaptive dilata-
tion to this transient systolic function reduction (a relevant
increase in chamber dimension to compensate for a
reduced contractility): even if referred to as ‘‘dilatation’’
also by some recent echocardiographic literature[54], no
acute relevant increase of LV size beyond upper limits of
Fig. 5 Sepsis-related myocardial dysfunction. Septic shock in a
patient with community-acquired pneumonia (same patient of Fig. 3).
Repeated TEE assessments (mid-esophageal 4-chamber views). At
ICU admission [SAP 110/70 mmHg, HR 118 bpm, norepinephrine
0.4 mcg/(kg min)] a pattern of severe biventricular dysfunction is
detected (Video 5A ESM), as evidenced by a small reduction of both
ventricle’s size from end-diastole (a) to end-systole (d); measured EF
is 15%, TAPSE 12,9 mm, CO 3,59 L/min. Hemodynamic improve-
ment occurs after epinephrine infusion at [0.1 mcg/(kg min)] (b–e,
Video 5B ESM): SAP 140/76, HR 122 bpm, EF 25%, TAPSE
15.7 mm, CO 4.83 L/min. On day 12 patient is weaned from
vasoactive drugs (c–f, Video 5C ESM): SAP 130/68, HR 93 bpm, EF
58%, TAPSE 21.1 mm, CO 6.43 L/min. Note that the LV looks
dilated in a and b, but only if compared with its size after recovery
(c), and not as absolute value (LV EDV = 146 ml, upper range of
normality). RA right atrium, RV right ventricle, LA left atrium, LV left
ventricle, EF ejection fraction, TAPSE tricuspid annulus plane
systolic excursion, CO cardiac output
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the normality range is to be expected in a previously
healthy septic-depressed LV [53, 55], but rather changes is
LV size according to different loading conditions in dis-
tinct phases of SS. Of note, ECG helps to distinguish
between acute coronary syndrome-determined dysfunction
triggered by sepsis (with electrical signs of ischemia) from
true sepsis-related myocardial dysfunction (negative ECG
for ischemia). Cardiac troponins show increases in both
cases [56]. Myocardial perfusion ECHO may be a prom-
ising technique to allow for differential diagnosis [57].
RV systolic dysfunction
RV systolic dysfunction can also develop in SS, and it is been
described in up to one-third of patients [14, 58]. It can either
be part of biventricular dysfunction or represent an isolated
RV dysfunction. Intrinsic depression of RV myocardial
function is detected as RV hypokinesia, and semi-quantita-
tively appreciated as a variable degree of RV dilatation (with
RV end-diastolic area, RVEDA, to LV end-diastolic area,
LVEDA, ratio measurement in a four chamber view). When
RV systolic overload (due to ARDS, mechanical ventilation)
develops [59], or even worse superimposes on an already
poor RV function, an overt state of acute cor pulmonale can
appear, and it is revealed by septal dyskinesia (Fig. 7, Video
7A, B) [60]. With introduction of lung protective ventilation
strategies, frequency of this phenomenon has markedly
decreased [61], and RV dilatation represents the most fre-
quent finding. Such as LV dysfunction may be unmasked by
vasoconstrictors administration, so can RV failure become




Same patient of Fig. 1 (hospital-
acquired pneumonia, 3rd
postoperative month of double-
lung transplant), 18 h later, after
volume resuscitation, infusion
of norepinephrine [1 mcg/
(kg min)], vasopressin
0.02 U/min, now again unstable
(SAP 90/60, HR 121 bpm, low
cardiac output). TTE subcostal
4-chamber view (upper panels,
Video 6A ESM) and parasternal
short axis midpapillary view
(middle panels, Video 6B ESM)
show a severely depressed LV
systolic function with negligible
reduction of LV size from end-
diastole (a, c) to end-systole
(b, d). RV shows preserved
systolic function. The IVC
(subcostal IVC view, lower
panels) is now larger (e) with
absent inspiratory increase at
mechanical passive inspiration
(f). RA right atrium, RV right
ventricle, LA left atrium, LV left
ventricle, IVC inferior vena
cava, SAP systemic arterial
pressure, HR heart rate
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manifest only upon institution of mechanical ventilation.
Time course of sepsis-related RV dysfunction resembles that
of LV dysfunction [48]. Whenever detected as main hemo-
dynamic feature (in the ARDS setting), not only inotropes
administration but also vasoconstrictors upward titration is
indicated, together with low plateau pressure of ventilation;
this hemodynamic pattern may also represent an indication
for inhaled nitric oxide administration and for patient’s
pronation [60, 61].
Low peripheral vascular tone
Echocardiography offers theoretically the tools to calculate
systemic arterial vascular resistance but with a cumbersome
method and infrequent clinical applicability. In clinical
practice, sepsis-related vasodilatation is diagnosed with
exclusion criteria: persistence of hypotension despite ade-
quate preload and preserved (or pharmacologically normal-
ized) biventricular systolic function, and thus absence of a
low-output state, invariably means a need for an increase in
systemic arterial vascular tone [15]. As mentioned above,
also in some situations of volume responsiveness upward
titration of vasoconstrictors is indicated.
LV diastolic dysfunction, LV filling pressure
Additionally, assessment of LV diastolic properties and LV
filling pressures estimation may be of use. Diastolic dys-
function has been demonstrated in SS patients using rela-
tively preload-independent parameters, based on mitral
annulus tissue Doppler and mitral inflow propagation
velocity; not only as associated with systolic dysfunction,
but also as isolated impairment of LV relaxation [62, 63].
Even if clinical implications of this still have to be fully
clarified, practical impact may be derived for patients with
isolated diastolic dysfunction and evidence of elevated LV
filling pressures in the context of hypoxemia: fluid
restriction and diuretics are then consistent choices
(patients with systolic dysfunction do not viceversa risk to
remain undetected, as they already usually are submitted to
such a tretment, toghether with inotropes). Various Dopp-
ler-derived parameters provide estimation of LV filling
pressure with good correlation to invasively measured
pulmonary artery occlusion pressure (PAOP), specifically
in septic shock patients populations [64]. In mechanically
ventilated patients, mitral E/A \ 1.4, pulmonary vein
S/D [ 0.65 and systolic fraction [44% best predict a
Fig. 7 Acute cor pulmonale in septic shock. Septic shock in
community-acquired pneumonia superimposed on chronic pulmonary
hypertension (pulmonary fibrosis). TEE midesophageal 4-chamber
view (upper panels, Video 7A ESM) and transgastric midpapillary
short axis view (lower panels, Video 7B ESM). SAP 100/53 mmHg,
HR 123 bpm, low cardiac output. Norepinephrine [1 mcg/(kg min)]
is infused. The RV looks markedly dilated (its end-diastolic area is
bigger than the LV area (7A, RVEDA/LVEDA [ 1), and hypokinetic
(small reduction of its size from end-diastole, a, to end-systole, b).
The interventricular septum is flattened (a, c) and shows a paradoxical
motion at end-systole (b, d, red arrow). RA right atrium, RV right
ventricle, LA left atrium, LV left ventricle, RVEDA RV end-diastolic
area, LVEDA LV end-diastolic area
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PAOP B 18 mmHg [65]; lateral E/E0 \ 8.0 or E/Vp \ 1.7
predicts a PAOP B 18 mmHg with a sensitivity of 83 and
80% [65]; mitral E/A [ 2 predicts a PAOP [ 18 mmHg
with 100% positive predictive value [66].
A structured approach integrating assessment of these
hemodynamic targets into a practical algorithm is proposed
in Fig. 8.
Cardiac source of sepsis
Infective endocarditis (IE) is a microbial infection of
intracardiac structures facing the blood. It can be encoun-
tered in ICU patients mainly in two scenarios: (A) as cause
of admission, due to severity of its complications leading to
cardiogenic shock in a febrile context, or to pure septic
shock; (B) as acquired infection during ICU stay, leading to
a septic state with no evident focus.
• IE on native or prosthetic valves is defined on the bases
of a well-established set of diagnostic criteria [67, 68],
and echocardiography provides for one of the major
ones. IE is a severe disease with a high mortality,
ranging from 20 to 25% [69] and up to 45% in patients
then admitted to ICU [70]. Echocardiography highly
contributes to IE diagnosis, allows for severity assess-
ment, and has a pivotal role in IE management and
decision making both on therapy and complications
[71, 72].
Fig. 8 Septic Shock ECHO-based goal-directed algorithm. To mon-
itor hemodynamics in septic shock the targets of the echocardio-
graphic investigation are organized in a systematic five-step approach.
Starting point is to detect potential signs of pre-existing chronic
cardiac dysfunction (Step 1): LV or LA significant dilatation, and LV
marked hypertrophy are signs or chronic volume/pressure overload;
RA significant dilatation, RV dilatation and hypertrophy have the
same meaning for right-side chronic disease (isolated RV dilatation
can vice versa be a sign of acute RV dysfunction). If unrecognized,
these findings can mislead in interpretation of subsequent findings
(i.e. primary cardiogenic cause of shock, instead of sepsis; wrong
assessment of volume status based on LV or RV dimensions). LV and
RV systolic function must then be assessed (Step 2), together with
cardiac output Doppler measurement (Step 3). A low output state can
then be ascribed to sepsis-related LV systolic dysfunction (associated
or not to RV dysfunction) or isolated RV dysfunction, and treated
accordingly. Low output with evidence of normal biventricular
systolic function should prompt investigation of volume status
(Step 4): overt hypovolemia or presence of volume responsiveness
will lead to fluid infusion. When inadequacy of global perfusion
and/or hypotension is associated with a non-low output state,
persistent preload defect should be investigated (again step four)
and if detected corrected. If this is not the case, an exclusion diagnosis
of vasodilatation is made (Step 5), and systemic arterial tone corrected
with upward titration of vasopressors. Whenever this is done, LV
systolic function should subsequently be re-assessed, as normalization
of LV afterload can unmask sepsis-related myocardial dysfunction. If
chronic LV failure is found, or LV dysfunction develops acutely, LV
filling pressure estimation is mandatory, to guide fluid management
and differential diagnosis of potential hypoxemia and pulmonary
edema (cardiogenic vs. non cardiogenic). ScvO2 central venous
saturation, LV left ventricle, RV right ventricle, SV stroke volume,
CI cardiac index, SAPm mean systemic arterial pressure
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Three potential ECHO findings are deemed to be
important criteria in establishing an IE diagnosis
(Table 4): (A) mobile echo dense mass attached to
valvular or mural endocardium or to implanted material
(Fig. 9a–d, Video 9A, B, Video 10–11 ESM), (B) para-
valvular fistulae or abscess formation (Fig. 9d, Video 12
ESM), and (C) new disruption or dehiscence of a
prosthetic valve (paravalvular leak) (Video 13 ESM).
In severely damaged native valves (especially rheu-
matic), clear identification of small vegetations may be
very difficult. Differential diagnosis between prosthetic
valve IE and non-obstructive thrombus, or between
bioprosthetic valve IE and degeneration, can be very
challenging.
Relevant differences in diagnostic accuracy for IE
exist between the transthoracic and the transesophageal
technique. Compared with TTE [73, 74], TEE has greater
sensitivity on small vegetations and on mitral valve IE.
Both techniques reach high specificity in equal manner,
and detection of a vegetating mass with focused TTE in
first approach to a shocked patient can be lifesaving.
The clinical context influences TTE and TEE diagnostic
capability [75]: while with low IE pre-test probability a
negative good-quality TTE can exclude the diagnosis,
TEE should be performed on all TTE negative cases with
a more-than-low clinical suspicion.
In mechanically ventilated ICU patients TEE is almost
invariably needed. It is then mandatory in the assessment
of suspected prosthetic valves IE, and in TTE positive
cases to identify major valvular complications and guide
surgical planning [76].
Of particular note is that the clinical presentation of IE
in acutely ill patients can be very much variable, ranging
from a febrile state, to septic or cardiogenic shock, to
any embolic manifestation. Echocardiography alone
cannot be used to make diagnosis of IE: a combination
of clinical-instrumental-microbiological criteria is
required, and differential diagnosis between IE vegeta-
tions and other intracardiac masses should always be
considered.
Even if one-third to a half of IE develop in absence of
pre-existing cardiac pathology or prosthetic devices, a
high suspicion for IE should be kept for septic patients
with prosthetic valves, implantable devices, or known
significant native valve pathology, and for ICU bacte-
riemic patients with unknown septic focus.
• IE on indwelling central venous catheters or implant-
able devices (pace-makers, internal cardioverters-defi-
brillators) is uncommon due to the lack of the
hemodynamic factors usually involved in IE pathogen-
esis (flow turbulence, high pressure gradients) [77], but
is getting more frequent as a consequence of develop-
ment and increased use of invasive diagnostic and
therapeutic procedures. In an ICU septic patient with no
other clear infective focus it should thus be considered,
especially if evidence of pulmonary septic embolism
exists [78] (Fig. 9e, f, Video 14 ESM). Besides
searching for vegetations on the catheter, from superior
vena cava to its implantation on the myocardium, the
ECHO exam should seek carefully for IE-associated
localizations on right heart valves [77–81]. Visualizing
vegetations on implantable devices (mass or sleeve-
like) may be difficult, due to artifacts coming from the
device itself. Small fibrin strands may represent a
difficult differential diagnosis.
• Septic thrombus on temporary central venous catheters
in ICU patients [82] and right heart endocarditis
following pulmonary heart catheterization have also
been described [83]. Finding of masses on central
venous catheters, more frequent, should prompt to
consider non-septic thrombosis as differential diagnosis
with EI. Microbiological data become obviously
crucial.
Limitations of Echo in diagnosis and monitoring
the critical septic patient
Even if ECHO has been extensively validated as accurate
and safe, and is currently employed on septic critical
patients by many clinicians, real outcome data related to its
use (beyond simple demonstration on impact on patient
management) are lacking.
Limitations in its use also exist. Low echogenicity at
surface examination matched with contraindications to
TEE clearly prevent its use. Whenever there is strict
requirement of continuous monitoring (of cardiac output or
pulmonary artery pressure) or precise measurement rather
than estimation of deemed relevant variables (mainly
PAOP or extravascular lung water), ECHO is not the right
tool. In centres where a tradition and adequate training on
the use of critical care ECHO exist, this is no frequent [14],
and repeated bedside assessment and semi-quantification of
hemodynamic variables enable use of ECHO alone as
monitoring tool. As it happens with targets of critical care
Table 4 Echocardiographic findings suggestive of endocarditis
Mobile echo dense mass attached to valvular/mural endocardium,
or to implanted material
Paravalvular fistulae or abscess formation
New disruption or dehiscence of a prosthetic valve (paravalvular
leak)
Even if echocardiography alone cannot be used to make diagnosis of
infective endocarditis, combination of clinical-instrumental-micro-
biological criteria with detection of at least one of these findings does
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practice other than hemodynamics, integrated monitoring
remains fundamental, and ECHO is in the best position to
be used in conjunction with other devices (pulse contour
technique based cardiac output monitors, pulmonary artery
catheter, PiCCO) [13]. Indeed, it can guide choice between
them and timing of use. A final issue is represented by time
required to the clinician to acquire sufficient competence in
critical care ECHO. For applications beyond focused
ECHO, particularly comprehensive hemodynamic moni-
toring, the training may in fact be demanding [8], and not
all physician may be willing to undergo a dedicated
training.
Fig. 9 Infectious endocarditis in ICU patients. a Patient with septic
shock, acute pulmonary edema, and systemic arterial embolization
(TEE midesophageal long axis view): massive mobile vegetation
(white arrow) on native aortic valve (right cusp; note also anatomic
disruption of the non-coronary cusp). See also Video 9A, B ESM.
b Febrile dyspnoeic patient (TEE midesophageal long axis view): thin
vegetations and cusps perforation on native aortic valve (white
arrows). See also Video 10 ESM. c Septic shock patient (TEE
midesophageal commissural view): small linear vegetation (white
arrow) on prosthetic valve in mitral position. See also Video 11 ESM.
d Patient with cardiac tamponade (bloody fluid at pericardiocentesis)
and septic shock (TEE midesophageal 2-chamber view): huge mobile
vegetation incorporating the posterior mitral leaflet (white arrow);
note sub-annular abscess and escavation (red arrow) responsible for
subacute LV wall rupture and hemopericardium. See also Video 12
ESM. In Video 13 ESM see in another febrile ICU patient a
paravalvular leak, regurgitant jet originating outside the prosthetic
valve annulus (red arrow; TEE midesophageal 2-chamber view,
mechanical bileaflet valve in mitral position). e Febrile patient with
dilated cardiomyopathy and biventricular pacing device (TEE bicaval
view): thrombus is evident in the SVC (red arrow), attached to the
pacemaker wire (white arrow). See also Video 14 ESM. Note
pulmonary embolic lesion at CT-scan (f, red arrow). RA right atrium,
LA left atrium, LV left ventricle, Asc AO ascending aorta, SVC
superior vena cava
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Conclusions
Echocardiography marries diagnostic capability with
monitoring accuracy, morphological assessment with
functional investigation. In the complex scenario of the
critical septic patient it has therefore the potential to be
regarded as an ideal monitoring tool, in most circumstances
used alone, sometimes in combination with other devices.
Beyond the very first stages of septic shock, where focused
ECHO may suffice, a comprehensive systematic ECHO
assessment of cardiac output, left and right systolic ven-
tricular function, volume status and filling pressures is
required, and allows for effective hemodynamic manage-
ment. Unfortunately, outcome studies on the use of ECHO
in septic shock are lacking, and are therefore strongly
advocated. As a matter of fact, availability of ECHO
equipment and adequate training remain actual major
limitations on a wider use of ECHO in this setting.
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